Waters Corp. (WAT), Tuesday announced that its shareholders have approved the issuance of Waters common stock to shareholders of Becton, Dickinson and Company (BDX) as part of the proposed combination of the latter's Biosciences & Diagnostic Solutions business with the company.
At the company's Special Meeting of Shareholders, the proposal received favorable votes from approximately 99 percent of shares present in person or by proxy.
With this approval, the company is planning to close the transaction on February 9, 2026.
"We appreciate the continued support of our shareholders as we move closer to completing this transaction," said CEO Udit Batra. "We look forward to creating meaningful value for patients, customers, employees, and shareholders alike."
Currently, WAT is trading at $390.54, down 0.09 percent, and BDX is trading at $203.36, down 0.02 percent on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.